(Press-News.org) On behalf of the Federal Ministry of Health (BMG), the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether specific methodological aspects have to be considered in the conduct, analysis and assessment of the certainty of results of studies on rare diseases. Within the framework of the same commission, the Institute also analysed the underlying studies for the approval of so-called orphan drugs, i.e. drugs for rare diseases, in Europe.
The result: For a different approach than in more common diseases, there are neither scientific reasons nor specific designs and methods that would not also be relevant for more common diseases. This is the case for both drug and non-drug treatments. If compromises have to be made with regard to the reliability of the conclusions because of a particularly small number of participants, raising the significance level is preferable to a limitation of the external or even internal validity of the studies.
Focus on rare diseases
In the European Union diseases are classified as rare if they occur in not more than 5 per 10 000 inhabitants. Very rare diseases are diseases that affect fewer than 2 per 100 000 inhabitants. Of approximately 30 000 known diseases, 7000 to 8000 are considered rare, so that in Germany alone up to 4 million people are affected.
The German National Action League for People with Rare Diseases (NAMSE), founded in 2010, has developed a catalogue of policy proposals, which, among other things, includes the development of criteria for the assessment and analysis of studies with few participants. Against this background, the BMG awarded a two-part commission to IQWiG, which has now published the results in a so-called rapid report. Its contents follow the rapid report on the evidence in guidelines on rare diseases, which IQWiG produced in 2011, also on behalf of the BMG.
RCT as the gold standard
As explained in the IQWiG report, there are four key components that primarily determine the reliability of the conclusions of a study: the internal validity (i.e. the risk of bias), external validity (i.e. applicability), effect size, and precision of the results. The risk of bias can be minimized by randomization, double-blinding, and the so-called intention-to-treat principle, i.e. within the framework of randomized controlled trials (RCTs).
Study sponsors occasionally argue that the methodological standards that are usually applied in clinical studies should be lowered for rare diseases. They justify this by claiming that RCTs are difficult to conduct due to the low number of participants, and that they are also ethically doubtful if effective comparator therapies are lacking. However, IQWiG reached a different conclusion: A low number of participants is equally problematic in all study types, and controlled studies are only ethically doubtful if the benefit or added benefit of the intervention under investigation is more or less proven already. However, further studies to clarify the question on benefit are then unnecessary anyway – not only in rare diseases.
Raising the significance level, if essential
Just like reduced internal validity, which increases the risk of bias, concessions on external validity can also lead to systematic errors, which cannot be adjusted for even with the most sophisticated statistical method.
Small effect sizes can only be determined with certainty by sufficiently large sample sizes in studies. Supraregional and international networks as well as disease registries that are as complete as possible are useful to collect a sufficient number of evaluable cases. The use of efficient statistical methods, e.g. sequential study designs, may allow for smaller sample sizes without affecting internal or external validity.
If this is not sufficient in the case of very rare diseases, IQWiG recommends compromising on precision: raising the significance level, e.g. from the usual five to ten percent, to obtain statistically significant results despite a small sample size. This makes it possible to at least quantify the probability of error: The uncertainty of a decision is known.
Empirical data support methodological expertise
For the second goal of the commission, IQWiG examined all 85 drug approvals for rare and very rare diseases in Europe between 2001 and 2013. 82 out of the 125 studies submitted within the framework of these approvals were RCTs, which clearly shows that it is not necessary to compromise on methodology. Most studies were multicentre, multinational, and multicontinental. Specific statistical methods aiming for high efficiency were used in about two thirds of the studies.
All patients have a right to quality
"It has been shown that in studies on rare diseases, deviation from the methods usually applied in studies is neither necessary nor possible without compromising on quality", concludes the Institute's Director Jürgen Windeler. "In most cases, reservations concerning RCTs in rare diseases are unwarranted."
The EU regulation No. 141/2000 already stipulated that patients suffering from rare conditions should be entitled to the same drug quality, safety and efficacy as other patients and that orphan drugs should therefore be subjected to the normal evaluation process. "The best way to do justice to these requirements is to conduct multicentre RCTs, in which the risk of bias is minimized and the data recorded are carefully analysed", says Windeler. "This makes it possible to estimate with sufficient certainty the benefit and harm of the intervention for the people affected, despite the small numbers of participants."
INFORMATION:
Process of report production
The BMG commissioned IQWiG in December 2013. The report was to be prepared in an accelerated procedure as a "rapid report". In contrast to the usual procedure, no preliminary reports are published here. Although a draft version of the report is reviewed by external experts, no hearing at which all interested parties can comment takes place. The report was sent to the commissioning agency on 8 September 2014.
An overview of the background, methods and further results of the report is provided in the executive summary.
Multiple pathways exist to a low greenhouse gas future, all involving increased efficiency and a dramatic shift in energy supply away from fossil fuels. A new tool 'SWITCH' enables policymakers and planners to assess the economic and environmental implications of different energy scenarios. It is presented today at the congress Global Challenges: Achieving Sustainability, hosted by the University of Copenhagen.
"SWITCH is a tool we can use to examine the different choices of technologies within the electrical power sector and their locations. It enables us to estimate ...
For teenagers, learning to establish a healthy degree of autonomy and closeness in relationships (rather than easily giving in to peer pressure) is an important task. A new longitudinal study has found one reason adolescents struggle with balancing autonomy and closeness in relationships: parents' psychological control. Teens whose parents exerted more psychological control over them when they were 13 had more problems establishing friendships and romantic relationships that balanced closeness and independence, both in adolescence and into early adulthood.
The study, ...
The lives of adolescents at home and at school may seem quite separate, but recent research has highlighted important connections. Family conflict and problems at school tend to occur together on the same day and sometimes even spill over in both directions to the next day, with family conflict increasing the likelihood of problems at school and vice versa. Now a new study has found that conflicts at home spill over to school and school problems influence problems at home up to two days later, and that negative mood and psychological symptoms are important factors in the ...
While losses in family income predict increases in behavior problems for many children, attending high-quality early childhood education and care centers offers some protection against families' economic declines, according to a new study out of Norway. In Norway, publicly subsidized high-quality early childhood education and care is available to all children, from low-income to affluent, starting at age 1. The study found that children who don't take part in such programs have more early behavior problems when their families' income drops.
The study was conducted by ...
Many different microbes can cause pneumonia, and treatment may be delayed or off target if doctors cannot tell which bug is the culprit. A novel approach—analyzing a patient's breath for key chemical compounds made by the infecting microbe—may help detect invasive aspergillosis, a fungal infection that is a leading cause of mortality in patients with compromised immune systems, according to a proof-of-concept study now online in Clinical Infectious Diseases.
Currently difficult to diagnose, this type of fungal pneumonia often requires a lung biopsy for definitive ...
A rare form of a devastating disease which causes low blood sugar levels in babies and infants may now be recognised earlier thanks to a new test developed by researchers from The University of Manchester.
Congenital hyperinsulinism starves a baby's brain of blood sugar and can lead to lifelong brain damage or permanent disability according to previous research carried out by the Manchester team. The condition occurs when specialised cells in the pancreas release too much insulin which causes frequent low sugar episodes - the clinical opposite of diabetes. Treatment ...
Researchers at Queen's University Belfast have discovered that music therapy reduces depression in children and adolescents with behavioural and emotional problems.
In the largest ever study of its kind, the researchers in partnership with the Northern Ireland Music Therapy Trust, found that children who received music therapy had significantly improved self-esteem and significantly reduced depression compared with those who received treatment without music therapy.
The study, which was funded by the Big Lottery fund, also found that those who received music therapy had ...
Scientists from the University of Southampton have revealed that feather shafts are made of a multi-layered fibrous composite material, much like carbon fibre, which allows the feather to bend and twist to cope with the stresses of flight.
Since their appearance over 150 million years ago, feather shafts (rachises) have evolved to be some of the lightest, strongest and most fatigue resistant natural structures. However, relatively little work has been done on their morphology, especially from a mechanical perspective and never at the nanoscale.
The study, which is ...
ANN ARBOR, Mich. — Right out of the starting gate, Michigan's expansion of health coverage for the poor and near-poor holds lessons for other states that are still on the fence about expanding their own Medicaid programs under the Affordable Care Act, a new analysis shows.
In an article in the New England Journal of Medicine, a team of University of Michigan Medical School researchers publish the first analysis of the initial results from the Healthy Michigan Plan, which launched this past April.
In its first 100 days, the authors write, the plan enrolled 327,912 ...
Good news, bad news: The amount of trans fats we eat has declined over the last 30 years, but we're still consuming more than recommended.
In a study reported in the Journal of the American Heart Association, researchers reviewed results from a series of six surveys as part of the Minnesota Heart Survey in 1980-2009.
More than 12,000 adults 25-74 years old in the Minneapolis-St. Paul area revealed that:
Trans fat intake dropped by about one-third in men (32 percent) and women (35 percent).
Average intake of the omega-3 fatty acids (DHA and EPA) was steady, but ...
